Doctor Arnaud Bisson

Phenotypes and outcomes in patients with atrial fibrillation: a global unsupervised cluster analysis from Phase II/III of the GLORIA-AF registry

Event: EHRA 2024

Topic: Artificial Intelligence (Machine Learning, Deep Learning)

Session: Poster session on devices, others

Access

Like

Impact of environment and ethnicity on prognosis in AF patients: does the 'where' matter more than the 'who'?

Event: EHRA 2024

Topic: Hospital Information Systems, Electronic Medical Records, Clinical Decision Support

Session: Poster session on devices, others

Access

Like

Mortality prediction in patient with atrial fibrillation and 0 or 1 nongender-related CHA2DS2-Vasc risk factor using machine learning: a French nationwide study

Event: ESC Congress 2023

Topic: Public Health

Session: Digital advances in optimising cardiovascular health

Access

Like

Prediction of early death after atrial fibrillation diagnosis: a french nationwide study

Event: EHRA 2023

Topic: Artificial Intelligence (Machine Learning, Deep Learning)

Session: e-Cardiology/Digital Health

Access

Like

All-cause mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention

Event: ESC Congress 2020

Topic: Cardioversion and Defibrillation

Session: Blockbusters from the Young in Arrhythmias

Access

Like

Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement

Event: ESC Congress 2019

Topic: Aortic Valve Stenosis

Session: Transcatheter aortic interventions

Access

Like

Are the results of the CASTLE-AF trial reproducible in the real life? Clinical outcomes after catheter ablation for atrial fibrillation with heart failure in a nationwide cohort study

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation - Treatment

Access

Like

Clinical outcomes after catheter ablation for atrial fibrillation in elderly patients: a French nationwide cohort study

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation - Treatment

Access

Like

Is atrio-ventricular node ablation a neglected option after failure of atrial fibrillation ablation? a French nationwide cohort study

Event: EHRA 2019

Topic: Rate Control

Session: Atrial Fibrillation - Treatment

Access

Like

Patients with atrial fibrillation and a possibly temporary cause: a different prognosis when atrial fibrillation is paroxysmal or persistent?

Event: EHRA 2019

Topic: Defining Types of Atrial Fibrillation

Session: Atrial Fibrillation - Pathophysiology and Mechanisms

Access

Like

Doctor Arnaud Bisson

Contributor content

Phenotypes and outcomes in patients with atrial fibrillation: a global unsupervised cluster analysis from Phase II/III of the GLORIA-AF registry

Impact of environment and ethnicity on prognosis in AF patients: does the 'where' matter more than the 'who'?

Mortality prediction in patient with atrial fibrillation and 0 or 1 nongender-related CHA2DS2-Vasc risk factor using machine learning: a French nationwide study

Prediction of early death after atrial fibrillation diagnosis: a french nationwide study

All-cause mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention

Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement

Are the results of the CASTLE-AF trial reproducible in the real life? Clinical outcomes after catheter ablation for atrial fibrillation with heart failure in a nationwide cohort study

Clinical outcomes after catheter ablation for atrial fibrillation in elderly patients: a French nationwide cohort study

Is atrio-ventricular node ablation a neglected option after failure of atrial fibrillation ablation? a French nationwide cohort study

Patients with atrial fibrillation and a possibly temporary cause: a different prognosis when atrial fibrillation is paroxysmal or persistent?

ESC 365 is supported by

Doctor Arnaud Bisson Follow

Contributor content

Phenotypes and outcomes in patients with atrial fibrillation: a global unsupervised cluster analysis from Phase II/III of the GLORIA-AF registry

Impact of environment and ethnicity on prognosis in AF patients: does the 'where' matter more than the 'who'?

Mortality prediction in patient with atrial fibrillation and 0 or 1 nongender-related CHA2DS2-Vasc risk factor using machine learning: a French nationwide study

Prediction of early death after atrial fibrillation diagnosis: a french nationwide study

All-cause mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention

Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement

Are the results of the CASTLE-AF trial reproducible in the real life? Clinical outcomes after catheter ablation for atrial fibrillation with heart failure in a nationwide cohort study

Clinical outcomes after catheter ablation for atrial fibrillation in elderly patients: a French nationwide cohort study

Is atrio-ventricular node ablation a neglected option after failure of atrial fibrillation ablation? a French nationwide cohort study

Patients with atrial fibrillation and a possibly temporary cause: a different prognosis when atrial fibrillation is paroxysmal or persistent?

ESC 365 is supported by

Doctor Arnaud Bisson